Description
Clinical Development Metamorphoses into Translational and Clinical Research Services (T&CR)
In line with global innovation trends and the growing demand for integrated AI-driven analytics, we are proud to announce our evolution from Clinical Development services to Translational and Clinical Research (T&CR) services.
This transformation reflects our strategic commitment to bridging the gap between discovery sciences and clinical services. Through translational insights, T&CR is bringing together bioanalytical excellence, pharmacogenomic insights, adaptive trial designs, predictive modeling (PK/PD, PBPK), and computational data sciences to de-risk drug development lifecycles, thereby accelerating smarter, patient-focused therapies to the market more quickly.
With a global outlook and by leveraging precision sciences, T&CR will continue to drive value across early and late-phase clinical trials, regulated bioanalysis, drug repurposing, and strategic trial execution worldwide.